| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Simian Acquired Immunodeficiency Syndrome | 33 | 2013 | 110 | 5.250 |
Why?
|
| Simian Immunodeficiency Virus | 32 | 2013 | 133 | 4.730 |
Why?
|
| Chemokines | 18 | 2015 | 314 | 2.910 |
Why?
|
| Receptors, Chemokine | 7 | 2013 | 114 | 1.440 |
Why?
|
| Macaca mulatta | 30 | 2013 | 717 | 1.070 |
Why?
|
| Tuberculosis, Pulmonary | 7 | 2017 | 247 | 1.060 |
Why?
|
| Dendritic Cells | 15 | 2014 | 1085 | 1.020 |
Why?
|
| Lymph Nodes | 17 | 2014 | 2967 | 0.990 |
Why?
|
| Lung | 20 | 2015 | 3151 | 0.980 |
Why?
|
| Ferrets | 2 | 2014 | 25 | 0.970 |
Why?
|
| In Situ Hybridization | 23 | 2014 | 1037 | 0.920 |
Why?
|
| Macaca fascicularis | 14 | 2017 | 137 | 0.830 |
Why?
|
| Inflammation Mediators | 7 | 2017 | 423 | 0.800 |
Why?
|
| Receptors, Cell Surface | 6 | 2013 | 862 | 0.730 |
Why?
|
| Mycobacterium tuberculosis | 8 | 2014 | 426 | 0.690 |
Why?
|
| Lectins, C-Type | 5 | 2013 | 162 | 0.670 |
Why?
|
| Cell Adhesion Molecules | 6 | 2013 | 577 | 0.630 |
Why?
|
| Chemokine CCL20 | 3 | 2014 | 39 | 0.630 |
Why?
|
| Gene Products, nef | 4 | 2003 | 15 | 0.620 |
Why?
|
| HIV-1 | 10 | 2014 | 653 | 0.610 |
Why?
|
| Chemokine CXCL13 | 3 | 2013 | 21 | 0.600 |
Why?
|
| Interferon-gamma | 10 | 2014 | 1144 | 0.570 |
Why?
|
| Pneumocystis carinii | 3 | 2013 | 20 | 0.560 |
Why?
|
| Animals | 74 | 2017 | 59536 | 0.550 |
Why?
|
| Receptors, CCR6 | 2 | 2013 | 22 | 0.510 |
Why?
|
| Granuloma, Respiratory Tract | 4 | 2013 | 7 | 0.500 |
Why?
|
| Catechin | 2 | 2013 | 32 | 0.500 |
Why?
|
| Toll-Like Receptors | 4 | 2014 | 174 | 0.490 |
Why?
|
| Elephants | 1 | 2014 | 34 | 0.480 |
Why?
|
| Vesicular Transport Proteins | 2 | 2013 | 135 | 0.480 |
Why?
|
| Chemotaxis | 3 | 2013 | 138 | 0.470 |
Why?
|
| Paneth Cells | 1 | 2013 | 23 | 0.460 |
Why?
|
| Chemokine CXCL10 | 7 | 2019 | 105 | 0.460 |
Why?
|
| Intestine, Large | 1 | 2013 | 28 | 0.450 |
Why?
|
| Gene Expression Regulation | 8 | 2017 | 4053 | 0.450 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2013 | 62 | 0.450 |
Why?
|
| Chemokines, CC | 3 | 2008 | 36 | 0.450 |
Why?
|
| RNA, Messenger | 14 | 2017 | 6150 | 0.440 |
Why?
|
| Endothelium, Lymphatic | 2 | 2013 | 14 | 0.440 |
Why?
|
| Pneumonia, Pneumocystis | 2 | 2010 | 68 | 0.420 |
Why?
|
| Lymphoid Tissue | 4 | 2013 | 95 | 0.410 |
Why?
|
| Cell Migration Inhibition | 1 | 2011 | 16 | 0.400 |
Why?
|
| Interleukin-17 | 6 | 2017 | 250 | 0.390 |
Why?
|
| Cytokines | 7 | 2014 | 2809 | 0.390 |
Why?
|
| Chemokines, CXC | 3 | 2006 | 117 | 0.380 |
Why?
|
| Virus Replication | 14 | 2014 | 709 | 0.350 |
Why?
|
| Endothelial Cells | 2 | 2014 | 1048 | 0.340 |
Why?
|
| Intestinal Mucosa | 2 | 2013 | 1081 | 0.330 |
Why?
|
| RNA, Viral | 11 | 2007 | 671 | 0.330 |
Why?
|
| Forkhead Transcription Factors | 3 | 2013 | 778 | 0.330 |
Why?
|
| Chemokine CXCL12 | 1 | 2008 | 132 | 0.320 |
Why?
|
| Cloning, Molecular | 6 | 2014 | 1213 | 0.310 |
Why?
|
| Phylogeny | 4 | 2014 | 826 | 0.300 |
Why?
|
| Neutrophils | 5 | 2015 | 835 | 0.290 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2008 | 673 | 0.290 |
Why?
|
| HIV Infections | 10 | 2019 | 2134 | 0.290 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2015 | 93 | 0.280 |
Why?
|
| Receptors, CXCR3 | 4 | 2008 | 36 | 0.280 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2010 | 3639 | 0.280 |
Why?
|
| Leukemia Virus, Feline | 4 | 1996 | 5 | 0.280 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2005 | 23 | 0.270 |
Why?
|
| Macrophages | 7 | 2014 | 1304 | 0.270 |
Why?
|
| CD4-Positive T-Lymphocytes | 10 | 2014 | 1033 | 0.270 |
Why?
|
| Lymphatic Vessels | 1 | 2007 | 143 | 0.270 |
Why?
|
| Chemokine CXCL9 | 4 | 2012 | 22 | 0.270 |
Why?
|
| T-Lymphocytes | 9 | 2017 | 3869 | 0.270 |
Why?
|
| Acquired Immunodeficiency Syndrome | 4 | 2006 | 362 | 0.270 |
Why?
|
| DNA, Complementary | 3 | 2014 | 869 | 0.260 |
Why?
|
| Down-Regulation | 2 | 2001 | 2074 | 0.260 |
Why?
|
| Gene Expression Regulation, Viral | 3 | 2007 | 187 | 0.250 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2001 | 1146 | 0.250 |
Why?
|
| Cell Line | 11 | 2014 | 5114 | 0.250 |
Why?
|
| Antigens, CD | 8 | 2013 | 1385 | 0.250 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 4 | 2013 | 134 | 0.240 |
Why?
|
| Molecular Sequence Data | 12 | 2013 | 6089 | 0.240 |
Why?
|
| Receptors, Immunologic | 3 | 2013 | 309 | 0.240 |
Why?
|
| Th17 Cells | 3 | 2015 | 162 | 0.230 |
Why?
|
| Tuberculosis | 5 | 2014 | 548 | 0.230 |
Why?
|
| Amino Acid Sequence | 9 | 2013 | 4233 | 0.230 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2014 | 72 | 0.230 |
Why?
|
| Chemokine CCL19 | 3 | 2010 | 7 | 0.230 |
Why?
|
| Receptors, CCR7 | 3 | 2010 | 39 | 0.230 |
Why?
|
| Membrane Proteins | 4 | 2006 | 2819 | 0.220 |
Why?
|
| Pulmonary Aspergillosis | 2 | 2015 | 31 | 0.220 |
Why?
|
| Intestinal Diseases | 1 | 2003 | 121 | 0.220 |
Why?
|
| Immunohistochemistry | 12 | 2013 | 7548 | 0.210 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2014 | 1538 | 0.210 |
Why?
|
| Interleukin-1beta | 3 | 2019 | 300 | 0.210 |
Why?
|
| Vaccines, DNA | 2 | 2017 | 105 | 0.200 |
Why?
|
| Dideoxynucleosides | 3 | 2006 | 19 | 0.200 |
Why?
|
| Ligands | 4 | 2008 | 995 | 0.200 |
Why?
|
| Disease Models, Animal | 12 | 2015 | 7222 | 0.200 |
Why?
|
| B-Lymphocytes | 4 | 2014 | 1294 | 0.200 |
Why?
|
| Herpesvirus 8, Human | 2 | 2014 | 102 | 0.200 |
Why?
|
| Polylysine | 2 | 2010 | 17 | 0.190 |
Why?
|
| Mice | 23 | 2015 | 34495 | 0.190 |
Why?
|
| Poly I-C | 2 | 2010 | 29 | 0.190 |
Why?
|
| Carboxymethylcellulose Sodium | 2 | 2010 | 18 | 0.190 |
Why?
|
| Cells, Cultured | 9 | 2019 | 5637 | 0.190 |
Why?
|
| Trophoblasts | 2 | 2013 | 138 | 0.190 |
Why?
|
| Membrane Glycoproteins | 2 | 2004 | 1073 | 0.190 |
Why?
|
| CD28 Antigens | 1 | 2001 | 202 | 0.180 |
Why?
|
| CD3 Complex | 1 | 2001 | 314 | 0.180 |
Why?
|
| Neisseria gonorrhoeae | 1 | 2019 | 27 | 0.170 |
Why?
|
| Interleukin-8 | 2 | 2019 | 519 | 0.170 |
Why?
|
| Cell Culture Techniques | 2 | 2014 | 598 | 0.170 |
Why?
|
| CD4 Lymphocyte Count | 4 | 2014 | 297 | 0.170 |
Why?
|
| Encephalitis, Viral | 3 | 2006 | 30 | 0.170 |
Why?
|
| Virus Latency | 2 | 1997 | 78 | 0.160 |
Why?
|
| Sequence Alignment | 3 | 2013 | 844 | 0.160 |
Why?
|
| RNA Splicing | 2 | 1997 | 370 | 0.160 |
Why?
|
| Mycobacterium bovis | 2 | 2012 | 67 | 0.150 |
Why?
|
| Viral Load | 7 | 2014 | 493 | 0.150 |
Why?
|
| Cross Reactions | 1 | 2017 | 266 | 0.150 |
Why?
|
| Base Sequence | 9 | 2002 | 4917 | 0.150 |
Why?
|
| Viral Envelope Proteins | 3 | 2004 | 207 | 0.140 |
Why?
|
| Cervix Uteri | 3 | 2019 | 253 | 0.140 |
Why?
|
| Receptors, CXCR5 | 2 | 2013 | 27 | 0.140 |
Why?
|
| Granuloma | 1 | 2017 | 154 | 0.140 |
Why?
|
| Chemokine CCL21 | 2 | 2008 | 4 | 0.140 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2012 | 1016 | 0.140 |
Why?
|
| Microscopy, Confocal | 4 | 2013 | 663 | 0.130 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 376 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 11 | 2014 | 6942 | 0.130 |
Why?
|
| Immunity, Innate | 3 | 2015 | 677 | 0.130 |
Why?
|
| beta-Glucans | 1 | 2015 | 34 | 0.130 |
Why?
|
| Biomarkers | 3 | 2014 | 5047 | 0.130 |
Why?
|
| Binding Sites | 3 | 2011 | 2171 | 0.130 |
Why?
|
| Leukocytes, Mononuclear | 5 | 2019 | 709 | 0.130 |
Why?
|
| Spleen | 4 | 2008 | 676 | 0.130 |
Why?
|
| Chemokine CXCL5 | 1 | 2014 | 13 | 0.130 |
Why?
|
| Chemokines, CX3C | 2 | 2006 | 2 | 0.130 |
Why?
|
| Colon | 2 | 2013 | 670 | 0.130 |
Why?
|
| Central Nervous System Viral Diseases | 1 | 2014 | 13 | 0.130 |
Why?
|
| Mucous Membrane | 2 | 2013 | 271 | 0.130 |
Why?
|
| Cancer Vaccines | 2 | 2010 | 697 | 0.130 |
Why?
|
| Lymphocyte Activation | 7 | 2013 | 1688 | 0.120 |
Why?
|
| Interleukin-23 | 2 | 2011 | 29 | 0.120 |
Why?
|
| Influenza Vaccines | 2 | 2017 | 635 | 0.120 |
Why?
|
| Cord Factors | 1 | 2014 | 3 | 0.120 |
Why?
|
| Organ Specificity | 4 | 2012 | 699 | 0.120 |
Why?
|
| Apoptosis | 1 | 2008 | 7591 | 0.120 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2015 | 113 | 0.120 |
Why?
|
| Aspergillus fumigatus | 1 | 2015 | 135 | 0.120 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 2012 | 157 | 0.120 |
Why?
|
| Calgranulin B | 1 | 2013 | 22 | 0.120 |
Why?
|
| Calgranulin A | 1 | 2013 | 12 | 0.120 |
Why?
|
| Chemokine CXCL11 | 2 | 2011 | 11 | 0.120 |
Why?
|
| alpha-Defensins | 1 | 2013 | 16 | 0.120 |
Why?
|
| Sarcoma, Kaposi | 2 | 2014 | 187 | 0.120 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2015 | 155 | 0.120 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2013 | 37 | 0.120 |
Why?
|
| beta-Defensins | 1 | 2013 | 30 | 0.120 |
Why?
|
| RNA, Bacterial | 1 | 2013 | 80 | 0.120 |
Why?
|
| Mice, Knockout | 8 | 2015 | 5710 | 0.110 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2014 | 68 | 0.110 |
Why?
|
| HIV | 2 | 2010 | 229 | 0.110 |
Why?
|
| Hydrolases | 1 | 2014 | 123 | 0.110 |
Why?
|
| Mannose-Binding Lectins | 1 | 2013 | 29 | 0.110 |
Why?
|
| AIDS Vaccines | 2 | 2004 | 78 | 0.110 |
Why?
|
| RNA, Ribosomal | 1 | 2013 | 83 | 0.110 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2013 | 16 | 0.110 |
Why?
|
| Arterioles | 1 | 2013 | 36 | 0.110 |
Why?
|
| Tuberculosis Vaccines | 1 | 2013 | 12 | 0.110 |
Why?
|
| Th2 Cells | 2 | 2015 | 257 | 0.110 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2013 | 582 | 0.110 |
Why?
|
| Lipopolysaccharides | 1 | 2015 | 558 | 0.110 |
Why?
|
| Lipocalins | 1 | 2012 | 54 | 0.110 |
Why?
|
| Mycobacterium Infections | 1 | 2012 | 49 | 0.110 |
Why?
|
| Acute-Phase Proteins | 1 | 2012 | 79 | 0.110 |
Why?
|
| Transcription, Genetic | 2 | 2014 | 3154 | 0.110 |
Why?
|
| Inflammation | 6 | 2015 | 2522 | 0.110 |
Why?
|
| Viral Proteins | 2 | 2013 | 435 | 0.110 |
Why?
|
| CD8-Positive T-Lymphocytes | 5 | 2013 | 1586 | 0.110 |
Why?
|
| Open Reading Frames | 1 | 2013 | 250 | 0.110 |
Why?
|
| Protein Binding | 3 | 2013 | 3438 | 0.110 |
Why?
|
| Dinoprostone | 2 | 2010 | 208 | 0.100 |
Why?
|
| Gene Expression Profiling | 4 | 2014 | 5159 | 0.100 |
Why?
|
| Humans | 43 | 2019 | 261506 | 0.100 |
Why?
|
| Decidua | 1 | 2013 | 154 | 0.100 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2013 | 212 | 0.100 |
Why?
|
| Proteins | 2 | 2013 | 1963 | 0.100 |
Why?
|
| Latent Tuberculosis | 1 | 2013 | 82 | 0.100 |
Why?
|
| Macaca | 2 | 2009 | 95 | 0.100 |
Why?
|
| Interferon Inducers | 1 | 2010 | 9 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 2 | 2013 | 2483 | 0.100 |
Why?
|
| Dogs | 1 | 2013 | 1155 | 0.100 |
Why?
|
| Interleukin-5 | 1 | 2011 | 73 | 0.100 |
Why?
|
| Germinal Center | 1 | 2011 | 161 | 0.100 |
Why?
|
| Mice, Inbred BALB C | 3 | 2011 | 2314 | 0.100 |
Why?
|
| Chorionic Villi | 1 | 2010 | 17 | 0.100 |
Why?
|
| Oncogene Proteins | 1 | 2012 | 354 | 0.100 |
Why?
|
| Cholesterol | 1 | 2014 | 658 | 0.100 |
Why?
|
| Neovascularization, Physiologic | 1 | 2013 | 345 | 0.090 |
Why?
|
| Neutrophil Infiltration | 3 | 2015 | 109 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 2508 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 1062 | 0.090 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 314 | 0.090 |
Why?
|
| Feline Acquired Immunodeficiency Syndrome | 1 | 1990 | 3 | 0.090 |
Why?
|
| Vaccines, Subunit | 1 | 2010 | 124 | 0.090 |
Why?
|
| Brain | 6 | 2007 | 4113 | 0.090 |
Why?
|
| NF-kappa B | 3 | 2012 | 1549 | 0.090 |
Why?
|
| Pregnancy Trimester, First | 1 | 2010 | 127 | 0.090 |
Why?
|
| Cellular Reprogramming | 1 | 2012 | 189 | 0.090 |
Why?
|
| Adjuvants, Immunologic | 1 | 2013 | 657 | 0.090 |
Why?
|
| Intestine, Small | 1 | 2013 | 499 | 0.090 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2013 | 308 | 0.090 |
Why?
|
| Gene Expression | 4 | 2013 | 3570 | 0.090 |
Why?
|
| Blood Vessels | 1 | 2010 | 217 | 0.090 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2002 | 997 | 0.090 |
Why?
|
| Epithelium | 2 | 2019 | 720 | 0.090 |
Why?
|
| Glioma | 2 | 2010 | 1963 | 0.080 |
Why?
|
| Mice, Transgenic | 3 | 2013 | 4143 | 0.080 |
Why?
|
| Lentivirus Infections | 2 | 2005 | 6 | 0.080 |
Why?
|
| Eosinophilia | 1 | 2011 | 176 | 0.080 |
Why?
|
| Receptors, Virus | 2 | 2008 | 157 | 0.080 |
Why?
|
| Up-Regulation | 4 | 2012 | 2450 | 0.080 |
Why?
|
| Th1 Cells | 1 | 2010 | 250 | 0.080 |
Why?
|
| Anti-Infective Agents | 1 | 2012 | 446 | 0.080 |
Why?
|
| Transfection | 3 | 2001 | 2944 | 0.080 |
Why?
|
| Receptors, CCR4 | 1 | 2008 | 34 | 0.080 |
Why?
|
| Interleukin-2 | 2 | 2010 | 842 | 0.080 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2008 | 182 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 980 | 0.080 |
Why?
|
| Cell Movement | 4 | 2012 | 2466 | 0.080 |
Why?
|
| Lymphadenitis | 1 | 2008 | 39 | 0.080 |
Why?
|
| Fluorescein | 1 | 2007 | 41 | 0.080 |
Why?
|
| Immunity, Mucosal | 1 | 2008 | 108 | 0.080 |
Why?
|
| Pre-Eclampsia | 1 | 2010 | 212 | 0.080 |
Why?
|
| Klebsiella Infections | 1 | 2008 | 64 | 0.080 |
Why?
|
| Virus Internalization | 1 | 2008 | 88 | 0.080 |
Why?
|
| Trigeminal Ganglion | 1 | 2007 | 5 | 0.080 |
Why?
|
| Microcirculation | 1 | 2008 | 200 | 0.080 |
Why?
|
| Asthma | 1 | 2015 | 871 | 0.070 |
Why?
|
| Klebsiella pneumoniae | 1 | 2008 | 98 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2007 | 15 | 0.070 |
Why?
|
| Monocytes | 2 | 2010 | 788 | 0.070 |
Why?
|
| Peptides | 2 | 2012 | 1479 | 0.070 |
Why?
|
| Homeostasis | 2 | 2002 | 950 | 0.070 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2010 | 254 | 0.070 |
Why?
|
| Mice, SCID | 1 | 2011 | 1869 | 0.070 |
Why?
|
| RNA, Fungal | 1 | 2006 | 21 | 0.070 |
Why?
|
| Metapneumovirus | 1 | 2006 | 58 | 0.070 |
Why?
|
| Genes, env | 2 | 1998 | 11 | 0.070 |
Why?
|
| Nasopharynx | 1 | 2006 | 119 | 0.070 |
Why?
|
| STAT3 Transcription Factor | 1 | 2013 | 1121 | 0.070 |
Why?
|
| Paramyxoviridae Infections | 1 | 2006 | 86 | 0.070 |
Why?
|
| Polydeoxyribonucleotides | 1 | 2005 | 7 | 0.070 |
Why?
|
| Jurkat Cells | 2 | 2010 | 311 | 0.070 |
Why?
|
| Whooping Cough | 1 | 2006 | 62 | 0.070 |
Why?
|
| Macrophage Activation | 3 | 2013 | 148 | 0.070 |
Why?
|
| AIDS Dementia Complex | 1 | 2005 | 18 | 0.070 |
Why?
|
| Complement C1q | 1 | 2005 | 28 | 0.070 |
Why?
|
| Flow Cytometry | 3 | 2013 | 3033 | 0.070 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2005 | 78 | 0.070 |
Why?
|
| Organ Culture Techniques | 2 | 2019 | 241 | 0.070 |
Why?
|
| Interleukins | 1 | 2008 | 325 | 0.070 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2010 | 502 | 0.070 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 2 | 2003 | 18 | 0.070 |
Why?
|
| RNA | 2 | 2010 | 1013 | 0.060 |
Why?
|
| Sequence Homology | 1 | 2004 | 71 | 0.060 |
Why?
|
| Tryptophan Oxygenase | 1 | 2004 | 7 | 0.060 |
Why?
|
| SAIDS Vaccines | 1 | 2004 | 22 | 0.060 |
Why?
|
| Microglia | 1 | 2005 | 164 | 0.060 |
Why?
|
| Peyer's Patches | 1 | 2003 | 30 | 0.060 |
Why?
|
| Cats | 3 | 1996 | 166 | 0.060 |
Why?
|
| Female | 18 | 2019 | 141928 | 0.060 |
Why?
|
| DNA, Ribosomal | 1 | 2003 | 103 | 0.060 |
Why?
|
| Brain Diseases | 1 | 2007 | 403 | 0.060 |
Why?
|
| HLA-DR Antigens | 1 | 2003 | 173 | 0.060 |
Why?
|
| Chimera | 3 | 1993 | 145 | 0.060 |
Why?
|
| Biotin | 1 | 2003 | 69 | 0.060 |
Why?
|
| Antigen Presentation | 1 | 2004 | 272 | 0.060 |
Why?
|
| COS Cells | 2 | 2008 | 377 | 0.060 |
Why?
|
| Disease Progression | 5 | 2014 | 6682 | 0.060 |
Why?
|
| Cell Proliferation | 3 | 2014 | 7226 | 0.060 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2002 | 34 | 0.060 |
Why?
|
| Muscle, Smooth | 1 | 2003 | 236 | 0.060 |
Why?
|
| Male | 17 | 2017 | 123000 | 0.060 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 644 | 0.050 |
Why?
|
| Chemokines, C | 1 | 2002 | 10 | 0.050 |
Why?
|
| Species Specificity | 2 | 2002 | 777 | 0.050 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2014 | 87 | 0.050 |
Why?
|
| Jejunum | 1 | 2003 | 216 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 1130 | 0.050 |
Why?
|
| Lung Transplantation | 1 | 2006 | 359 | 0.050 |
Why?
|
| Skin | 1 | 2008 | 1259 | 0.050 |
Why?
|
| Langerhans Cells | 1 | 2002 | 50 | 0.050 |
Why?
|
| Immunocompromised Host | 1 | 2006 | 698 | 0.050 |
Why?
|
| Immune System | 1 | 2003 | 279 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2003 | 490 | 0.050 |
Why?
|
| Genes, nef | 1 | 2001 | 4 | 0.050 |
Why?
|
| Lectins | 1 | 2001 | 151 | 0.050 |
Why?
|
| Signal Transduction | 3 | 2015 | 11965 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2012 | 2864 | 0.050 |
Why?
|
| DNA, Viral | 3 | 2014 | 694 | 0.050 |
Why?
|
| Interferon-alpha | 1 | 2005 | 889 | 0.050 |
Why?
|
| Microarray Analysis | 2 | 2014 | 392 | 0.050 |
Why?
|
| Histidine | 1 | 2001 | 91 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 1487 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2001 | 329 | 0.050 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2001 | 189 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2002 | 469 | 0.050 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2014 | 235 | 0.050 |
Why?
|
| Acute Disease | 3 | 2012 | 2422 | 0.050 |
Why?
|
| Cytopathogenic Effect, Viral | 2 | 1997 | 39 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 650 | 0.050 |
Why?
|
| Models, Molecular | 1 | 2004 | 1732 | 0.040 |
Why?
|
| Gonorrhea | 1 | 2019 | 41 | 0.040 |
Why?
|
| Receptors, CCR5 | 2 | 2014 | 52 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 2003 | 2927 | 0.040 |
Why?
|
| Interleukin-6 | 2 | 2014 | 1038 | 0.040 |
Why?
|
| Genes, myc | 1 | 2000 | 358 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 3 | 2013 | 3203 | 0.040 |
Why?
|
| Immunization | 2 | 2010 | 397 | 0.040 |
Why?
|
| HIV-2 | 1 | 1998 | 10 | 0.040 |
Why?
|
| Melanoma | 2 | 2013 | 5317 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2000 | 483 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 1 | 1999 | 314 | 0.040 |
Why?
|
| DNA Probes | 1 | 1998 | 217 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2002 | 834 | 0.040 |
Why?
|
| Genotype | 2 | 2014 | 4109 | 0.040 |
Why?
|
| Genes, pol | 2 | 1996 | 8 | 0.040 |
Why?
|
| DNA Primers | 1 | 2000 | 1399 | 0.040 |
Why?
|
| Dendrites | 1 | 1999 | 196 | 0.040 |
Why?
|
| Interleukin-4 | 2 | 2010 | 284 | 0.040 |
Why?
|
| In Vitro Techniques | 2 | 1998 | 1618 | 0.040 |
Why?
|
| Cercocebus atys | 1 | 1996 | 13 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 3 | 2008 | 4367 | 0.040 |
Why?
|
| Genes, pX | 1 | 1996 | 4 | 0.040 |
Why?
|
| Paraparesis, Tropical Spastic | 1 | 1996 | 7 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2004 | 1230 | 0.040 |
Why?
|
| Mice, Inbred Strains | 1 | 2017 | 521 | 0.040 |
Why?
|
| Cell Hypoxia | 1 | 2017 | 328 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2013 | 4654 | 0.040 |
Why?
|
| Interleukin-12 | 2 | 2010 | 253 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2010 | 3341 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2010 | 2947 | 0.030 |
Why?
|
| Proviruses | 1 | 1996 | 21 | 0.030 |
Why?
|
| Defective Viruses | 1 | 1996 | 28 | 0.030 |
Why?
|
| Neoplasms | 3 | 2012 | 15193 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1993 | 261 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2013 | 4849 | 0.030 |
Why?
|
| Pyroglyphidae | 1 | 2015 | 12 | 0.030 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2017 | 242 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2012 | 1819 | 0.030 |
Why?
|
| Epitopes | 2 | 2010 | 685 | 0.030 |
Why?
|
| Genes, Viral | 2 | 1996 | 202 | 0.030 |
Why?
|
| Anti-Retroviral Agents | 2 | 2006 | 148 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2002 | 1491 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2000 | 686 | 0.030 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2014 | 18 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2014 | 66 | 0.030 |
Why?
|
| Chemotactic Factors | 1 | 2013 | 42 | 0.030 |
Why?
|
| Genes, gag | 1 | 1993 | 9 | 0.030 |
Why?
|
| Immunodeficiency Virus, Feline | 1 | 1993 | 17 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2015 | 587 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2014 | 227 | 0.030 |
Why?
|
| Gene Products, env | 1 | 1993 | 38 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1993 | 264 | 0.030 |
Why?
|
| Steroids | 1 | 2015 | 356 | 0.030 |
Why?
|
| Cytosol | 1 | 2014 | 238 | 0.030 |
Why?
|
| Antibodies, Neutralizing | 1 | 2017 | 541 | 0.030 |
Why?
|
| Neutralization Tests | 2 | 2008 | 299 | 0.030 |
Why?
|
| Pancreatitis-Associated Proteins | 1 | 2013 | 32 | 0.030 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2014 | 87 | 0.030 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2013 | 39 | 0.030 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2013 | 24 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 2014 | 347 | 0.030 |
Why?
|
| CHO Cells | 1 | 1993 | 311 | 0.030 |
Why?
|
| Siderophores | 1 | 2012 | 11 | 0.030 |
Why?
|
| Virus Activation | 1 | 1995 | 228 | 0.030 |
Why?
|
| Lipocalin-2 | 1 | 2012 | 65 | 0.030 |
Why?
|
| Macrophages, Alveolar | 1 | 2012 | 67 | 0.030 |
Why?
|
| Enterotoxins | 1 | 2013 | 112 | 0.030 |
Why?
|
| Epitope Mapping | 2 | 2003 | 108 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1993 | 362 | 0.030 |
Why?
|
| Cricetinae | 1 | 1993 | 706 | 0.030 |
Why?
|
| Influenza A virus | 1 | 2013 | 270 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1993 | 611 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2012 | 159 | 0.030 |
Why?
|
| Clone Cells | 1 | 1993 | 555 | 0.030 |
Why?
|
| Time Factors | 4 | 2011 | 12926 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2012 | 158 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2012 | 164 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2012 | 348 | 0.030 |
Why?
|
| Plasmids | 1 | 1993 | 837 | 0.020 |
Why?
|
| HIV Antigens | 1 | 1991 | 24 | 0.020 |
Why?
|
| Adult | 6 | 2017 | 77950 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 4821 | 0.020 |
Why?
|
| Monitoring, Immunologic | 1 | 2010 | 47 | 0.020 |
Why?
|
| Central Nervous System | 2 | 2007 | 436 | 0.020 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2010 | 23 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 848 | 0.020 |
Why?
|
| Vaccines, Attenuated | 1 | 1991 | 210 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2013 | 4078 | 0.020 |
Why?
|
| HIV Antibodies | 1 | 1991 | 102 | 0.020 |
Why?
|
| Antibodies, Blocking | 1 | 2010 | 91 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2010 | 3536 | 0.020 |
Why?
|
| Regeneration | 1 | 2013 | 279 | 0.020 |
Why?
|
| Immunophenotyping | 2 | 2006 | 1681 | 0.020 |
Why?
|
| Middle Aged | 5 | 2017 | 86204 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2010 | 208 | 0.020 |
Why?
|
| Pan troglodytes | 1 | 1991 | 207 | 0.020 |
Why?
|
| Iron | 1 | 2012 | 376 | 0.020 |
Why?
|
| Genetic Variation | 1 | 1998 | 2086 | 0.020 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2010 | 219 | 0.020 |
Why?
|
| Chemokine CCL22 | 1 | 2008 | 13 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2014 | 1442 | 0.020 |
Why?
|
| Placenta | 1 | 2013 | 516 | 0.020 |
Why?
|
| Models, Immunological | 1 | 2008 | 77 | 0.020 |
Why?
|
| Pregnancy | 2 | 2013 | 7573 | 0.020 |
Why?
|
| Receptors, Histamine H1 | 1 | 2008 | 7 | 0.020 |
Why?
|
| Cell Survival | 1 | 2014 | 3045 | 0.020 |
Why?
|
| Type C Phospholipases | 1 | 2008 | 53 | 0.020 |
Why?
|
| Neurons | 2 | 2014 | 2287 | 0.020 |
Why?
|
| Receptors, Interleukin | 1 | 2008 | 97 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2013 | 1234 | 0.020 |
Why?
|
| Antigens, CD20 | 1 | 2008 | 206 | 0.020 |
Why?
|
| Cell Death | 1 | 2010 | 671 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2010 | 1008 | 0.020 |
Why?
|
| Chemokine CX3CL1 | 1 | 2006 | 9 | 0.020 |
Why?
|
| Gene Products, gag | 1 | 2007 | 36 | 0.020 |
Why?
|
| Self-Sustained Sequence Replication | 1 | 2006 | 2 | 0.020 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2006 | 23 | 0.020 |
Why?
|
| Endocytosis | 1 | 2008 | 225 | 0.020 |
Why?
|
| Epithelial Cells | 2 | 2008 | 1818 | 0.020 |
Why?
|
| Gliosis | 1 | 2006 | 41 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2010 | 1519 | 0.020 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2007 | 64 | 0.020 |
Why?
|
| Nucleoproteins | 1 | 2006 | 37 | 0.020 |
Why?
|
| Peripheral Nervous System | 1 | 2007 | 42 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 1489 | 0.020 |
Why?
|
| Young Adult | 2 | 2017 | 21445 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2008 | 206 | 0.020 |
Why?
|
| Palatine Tonsil | 1 | 2006 | 53 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 1498 | 0.020 |
Why?
|
| Blood Cells | 1 | 2006 | 127 | 0.020 |
Why?
|
| CD40 Ligand | 1 | 2006 | 115 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2006 | 323 | 0.020 |
Why?
|
| Cell Count | 1 | 2007 | 508 | 0.020 |
Why?
|
| Viral Matrix Proteins | 1 | 2006 | 201 | 0.020 |
Why?
|
| Aged | 4 | 2017 | 70117 | 0.020 |
Why?
|
| Cystic Fibrosis | 1 | 2008 | 264 | 0.020 |
Why?
|
| Didanosine | 1 | 2004 | 5 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 2004 | 122 | 0.020 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2004 | 38 | 0.020 |
Why?
|
| Mathematics | 1 | 2004 | 136 | 0.020 |
Why?
|
| Chromogranin A | 1 | 2004 | 65 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2010 | 1271 | 0.020 |
Why?
|
| Administration, Intravaginal | 1 | 2004 | 10 | 0.020 |
Why?
|
| Chromogranins | 1 | 2004 | 84 | 0.020 |
Why?
|
| Encephalitis | 1 | 2005 | 143 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 6100 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2004 | 208 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2004 | 185 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 2010 | 1506 | 0.010 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2004 | 151 | 0.010 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2004 | 69 | 0.010 |
Why?
|
| Astrocytes | 1 | 2006 | 368 | 0.010 |
Why?
|
| Recurrence | 1 | 2010 | 4758 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 2330 | 0.010 |
Why?
|
| Respiratory Tract Infections | 1 | 2006 | 437 | 0.010 |
Why?
|
| Macaca nemestrina | 1 | 2001 | 16 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 4988 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 545 | 0.010 |
Why?
|
| Immunologic Memory | 1 | 2003 | 374 | 0.010 |
Why?
|
| Presynaptic Terminals | 1 | 2002 | 114 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2004 | 584 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2004 | 487 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2002 | 486 | 0.010 |
Why?
|
| Carcinoma | 1 | 2012 | 2578 | 0.010 |
Why?
|
| Prognosis | 2 | 2013 | 21713 | 0.010 |
Why?
|
| Rabbits | 1 | 2001 | 957 | 0.010 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2000 | 163 | 0.010 |
Why?
|
| Models, Animal | 1 | 2002 | 664 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 3254 | 0.010 |
Why?
|
| Rats | 1 | 2008 | 6086 | 0.010 |
Why?
|
| Papio | 1 | 1998 | 70 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 1999 | 261 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 4971 | 0.010 |
Why?
|
| Fibroma | 1 | 1998 | 85 | 0.010 |
Why?
|
| Gene Amplification | 1 | 2000 | 731 | 0.010 |
Why?
|
| Lymphatic Diseases | 1 | 1998 | 128 | 0.010 |
Why?
|
| Vaccination | 1 | 2004 | 1123 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 2012 | 3578 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1996 | 132 | 0.010 |
Why?
|
| Anti-HIV Agents | 1 | 1999 | 350 | 0.010 |
Why?
|
| Leukemia, T-Cell | 1 | 1996 | 87 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2012 | 8873 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2000 | 810 | 0.010 |
Why?
|
| Motor Activity | 1 | 1999 | 693 | 0.010 |
Why?
|
| Survivors | 1 | 2000 | 1031 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 14551 | 0.010 |
Why?
|
| Mutation | 1 | 2014 | 15179 | 0.010 |
Why?
|
| Viral Interference | 1 | 1993 | 7 | 0.010 |
Why?
|
| Viral Plaque Assay | 1 | 1993 | 48 | 0.010 |
Why?
|
| Cell Cycle | 1 | 1999 | 2084 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1993 | 121 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 29902 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 1999 | 786 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 1993 | 295 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1996 | 875 | 0.010 |
Why?
|
| Adolescent | 1 | 2013 | 31252 | 0.010 |
Why?
|
| Spinal Cord | 1 | 1996 | 690 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1998 | 1320 | 0.010 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 1991 | 62 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2000 | 6009 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2000 | 9180 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2000 | 9244 | 0.000 |
Why?
|
| Tumor Cells, Cultured | 1 | 1995 | 5395 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2006 | 32848 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 2000 | 13658 | 0.000 |
Why?
|
| Infant | 1 | 2000 | 13310 | 0.000 |
Why?
|